EXECUTIVE MANAGEMENT BIO
Michael R. Bleavins, Ph.D., DABT
President, Laboratory Center
office: 734.222.0013
mobile: 734.904.0020
email: bleavins@mtrinstitute.com
Dr. Bleavins is the President of the Laboratory Center. Dr. Bleavins retired from Pfizer in 2006 with more than 19 years of experience
in biomarkers, translational medicine, collaborations in Pharmaceutical Research and Development from Discovery to Phase 4 stages, and
application of new technologies to facilitate pharmaceutical decision making.
He has a Ph.D. in Environmental Toxicology and Animal Science from Michigan State University, with postdoctoral fellowships at the
University of Wisconsin-Madison and the General Motors Biomedical Sciences Research Laboratories. He is a Diplomate of the American
Board of Toxicology and a member of several scientific societies. He is Adjunct Professor of Pathology (Medical School) and Adjunct
Professor of Toxicology (School of Public Health) at the University of Michigan, and Adjunct Professor of Pharmaceutical Sciences at
Wayne State University.
Dr. Bleavins was responsible for extensive laboratory operations including biomarkers, clinical pathology, cell biology, molecular
biology, immunotoxicology, live-cell imaging, genetic toxicology, investigative pathology, pharmacogenomics, genomics, metabonomics,
proteomics, and biochemistry during his tenure at Pfizer. He has numerous publications in these areas and multi-species effects of
toxic agents. He is internationally recognized as an expert in biomarker development, validation, and translation, as well as
drug development, with invited lectures across the United States, United Kingdom, Europe, and Japan. Dr. Bleavins has significant
experience in successful multidisciplinary collaborations, bridging pre-clinical and clinical safety testing, clinical trial support,
academic collaborations, and application of emerging technologies.